PHG : Summary for Koninklijke Philips N.V. NY Reg - Yahoo Finance

U.S. Markets open in 5 hrs 10 mins

Koninklijke Philips N.V. (PHG)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
30.24-0.02 (-0.07%)
At close: 4:00PM EST
People also watch
STMULSNEUNCAJ
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close30.26
Open30.13
Bid0.00 x
Ask0.00 x
Day's Range30.13 - 30.39
52 Week Range23.00 - 30.79
Volume936,564
Avg. Volume1,386,130
Market Cap28.19B
Beta1.19
PE Ratio (TTM)34.29
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.90 (2.98%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Op-Ed: Why every company should be innovating with purpose
    CNBC2 days ago

    Op-Ed: Why every company should be innovating with purpose

    Even though we live in a fast-changing world with short-termism all around, it requires years of determination to transform a company.

  • PR Newswire7 days ago

    Philips announces new augmented-reality surgical navigation technology designed for image-guided spine, cranial and trauma surgery

    AMSTERDAM, Jan. 12, 2017 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a leader in integrated image-guided therapy solutions, today announced the development of an industry-first augmented-reality surgical navigation technology that is designed to help surgeons perform image-guided open and minimally-invasive spine surgery. Philips is a pioneer in hybrid operating room (hybrid OR) solutions to facilitate both surgical and minimally-invasive endovascular procedures, with over 750 hybrid ORs installed globally. The addition of this new augmented reality technology will further widen the scope of Philips hybrid OR solutions to other fast-growing areas of image-guided surgery including spine, cranial and trauma procedures.

  • PR Newswire10 days ago

    Philips and Illumina join forces to offer integrated genomics solutions for oncology

    AMSTERDAM and SAN DIEGO, Jan. 9, 2017 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Illumina, Inc. (ILMN), the global leader in DNA sequencing and array-based technologies, today announced a strategic collaboration that aims to integrate Illumina's sequencing systems for large-scale analysis of genetic variation and function and Philips' IntelliSpace Genomics clinical informatics platform, and to coordinate marketing and sales of the resulting solutions. Philips and Illumina will also seek to engage in clinical research collaborations with health systems in the US that want to develop precision medicine programs in oncology.